Otis W. Brawley

17.8k total citations · 8 hit papers
128 papers, 12.0k citations indexed

About

Otis W. Brawley is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Otis W. Brawley has authored 128 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Oncology, 39 papers in Pulmonary and Respiratory Medicine and 23 papers in Economics and Econometrics. Recurrent topics in Otis W. Brawley's work include Global Cancer Incidence and Screening (39 papers), Prostate Cancer Treatment and Research (27 papers) and Colorectal Cancer Screening and Detection (26 papers). Otis W. Brawley is often cited by papers focused on Global Cancer Incidence and Screening (39 papers), Prostate Cancer Treatment and Research (27 papers) and Colorectal Cancer Screening and Detection (26 papers). Otis W. Brawley collaborates with scholars based in United States, Austria and Finland. Otis W. Brawley's co-authors include Robert A. Smith, Durado Brooks, Richard C. Wender, Debbie Saslow, Deana Manassaram‐Baptiste, Stacey A. Fedewa, Vilma Cokkinides, Kimberly Andrews, William F. Anderson and Nilanjan Chatterjee and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Otis W. Brawley

126 papers receiving 11.7k citations

Hit Papers

Colorectal cancer screeni... 2005 2026 2012 2019 2018 2012 2010 2005 2017 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society
    2018 1.3k citations Andrew M. D. Wolf, Elizabeth T. H. Fontham et al. profile →
  2. Benefits and Harms of CT Screening for Lung Cancer
    2012 927 citations Otis W. Brawley et al. profile →
  3. Effect of Dutasteride on the Risk of Prostate Cancer
    2010 750 citations Otis W. Brawley et al. profile →
  4. Are Racial and Ethnic Minorities Less Willing to Participate in Health Research?
    2005 667 citations Otis W. Brawley et al. profile →
  5. Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening
    2017 473 citations Robert A. Smith, Kimberly Andrews et al. profile →
  6. Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening
    2018 438 citations Robert A. Smith, Kimberly Andrews et al. profile →
  7. 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
    2023 379 citations Otis W. Brawley et al. profile →
  8. Cancer screening in the United States, 2014: A review of current American Cancer Society guidelines and current issues in cancer screening
    2014 336 citations Robert A. Smith, Deana Manassaram‐Baptiste et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Otis W. Brawley United States 50 5.2k 4.1k 1.8k 1.7k 1.6k 128 12.0k
Limin X. Clegg United States 31 6.6k 1.3× 3.7k 0.9× 1.5k 0.8× 1.7k 1.0× 1.8k 1.2× 44 16.7k
Vilma Cokkinides United States 49 7.7k 1.5× 2.6k 0.6× 1.1k 0.6× 1.5k 0.9× 1.1k 0.7× 75 14.0k
Betsy Kohler United States 30 6.2k 1.2× 2.9k 0.7× 2.0k 1.1× 1.4k 0.8× 2.6k 1.7× 61 13.9k
Michel P. Coleman United Kingdom 61 6.7k 1.3× 2.2k 0.5× 1.2k 0.7× 1.4k 0.8× 1.3k 0.8× 291 13.3k
S. Jane Henley United States 59 6.6k 1.3× 3.2k 0.8× 2.4k 1.3× 1.8k 1.0× 2.9k 1.9× 123 18.7k
Lawrence N. Shulman United States 57 6.7k 1.3× 2.1k 0.5× 2.4k 1.3× 1.7k 1.0× 1.2k 0.7× 332 11.8k
Lori M. Minasian United States 49 3.6k 0.7× 2.8k 0.7× 1.2k 0.7× 1.5k 0.8× 2.0k 1.3× 201 9.9k
Otis W. Brawley United States 34 5.1k 1.0× 3.6k 0.9× 1.8k 1.0× 895 0.5× 2.3k 1.5× 61 11.5k
Elizabeth Garrett‐Mayer United States 56 3.8k 0.7× 2.4k 0.6× 1.8k 1.0× 1.5k 0.8× 3.3k 2.1× 339 13.1k
Kimberly Andrews United States 21 9.1k 1.7× 4.0k 1.0× 1.7k 0.9× 1.5k 0.8× 1.4k 0.9× 28 14.9k

Countries citing papers authored by Otis W. Brawley

Since Specialization
Citations

This map shows the geographic impact of Otis W. Brawley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Otis W. Brawley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Otis W. Brawley more than expected).

Fields of papers citing papers by Otis W. Brawley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Otis W. Brawley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Otis W. Brawley. The network helps show where Otis W. Brawley may publish in the future.

Co-authorship network of co-authors of Otis W. Brawley

This figure shows the co-authorship network connecting the top 25 collaborators of Otis W. Brawley. A scholar is included among the top collaborators of Otis W. Brawley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Otis W. Brawley. Otis W. Brawley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Lin, Channing J. Paller, Hwanhee Hong, et al.. (2021). Comparison of Treatments for Nonmetastatic Castration-Resistant Prostate Cancer: Matching-Adjusted Indirect Comparison and Network Meta-Analysis. JNCI Journal of the National Cancer Institute. 114(2). 191–202. 12 indexed citations
3.
Best, Jennie H., Shalini Mohan, Amanda M. Kong, et al.. (2020). Baseline Demographics and Clinical Characteristics Among 3471 US Patients Hospitalized with COVID-19 and Pulmonary Involvement: A Retrospective Study. Advances in Therapy. 37(12). 4981–4995. 11 indexed citations
4.
Sineshaw, Helmneh M., Kimmie Ng, W. Dana Flanders, Otis W. Brawley, & Ahmedin Jemal. (2017). Factors That Contribute to Differences in Survival of Black vs White Patients With Colorectal Cancer. Gastroenterology. 154(4). 906–915.e7. 96 indexed citations
5.
Oeffinger, Kevin C., Elizabeth T. H. Fontham, Ruth Etzioni, et al.. (2016). Breast Cancer Screening for Women at Average Risk. Obstetrical & Gynecological Survey. 71(3). 153–155. 5 indexed citations
6.
Johnson, Timothy V., Ammara Abbasi, Evan D. Schoenberg, et al.. (2014). Numeracy Among Trainees: Are We Preparing Physicians for Evidence-Based Medicine?. Journal of surgical education. 71(2). 211–215. 23 indexed citations
7.
Virgo, Katherine S., et al.. (2013). Health care policy and cancer survivorship. Cancer. 119(S11). 2187–2199. 17 indexed citations
8.
Shih, Ya‐Chen Tina, Patricia A. Ganz, Denise R. Aberle, et al.. (2013). Delivering High-Quality and Affordable Care Throughout the Cancer Care Continuum. Journal of Clinical Oncology. 31(32). 4151–4157. 49 indexed citations
9.
Brawley, Otis W.. (2012). Prostate Cancer Screening: What We Know, Don't Know, and Believe. Annals of Internal Medicine. 157(2). 135–136. 18 indexed citations
10.
Lund, Mary Jo, Eboneé N. Butler, Harvey L. Bumpers, et al.. (2008). High prevalence of triple‐negative tumors in an urban cancer center. Cancer. 113(3). 608–615. 75 indexed citations
11.
Lund, Mary Jo, Katrina F. Trivers, Peggy L. Porter, et al.. (2008). Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Research and Treatment. 113(2). 357–370. 336 indexed citations
12.
Hayes, Nikki, Armin D. Weinberg, Otis W. Brawley, et al.. (2005). Cancer-related Disparities: Weathering the Perfect Storm Through Comprehensive Cancer Control Approaches. Cancer Causes & Control. 16(S1). 41–50. 13 indexed citations
13.
Reddy, Sreekanth, et al.. (2003). Prostate cancer in black and white Americans. Cancer and Metastasis Reviews. 22(1). 83–86. 50 indexed citations
14.
Anderson, William F., Asad Umar, & Otis W. Brawley. (2003). Colorectal carcinoma in black and white race. Cancer and Metastasis Reviews. 22(1). 67–82. 54 indexed citations
15.
Brawley, Otis W. & Howard L. Parnes. (2000). Prostate cancer prevention trials in the USA. European Journal of Cancer. 36(10). 1312–1315. 49 indexed citations
16.
Reed, Eddie, Christa S. Zerbe, Otis W. Brawley, Annette Bicher, & Seth M. Steinberg. (2000). Analysis of Autopsy Evaluations of Ovarian Cancer Patients Treated at the National Cancer Institute, 1972–1988. American Journal of Clinical Oncology. 23(2). 107–116. 37 indexed citations
17.
Dawson, Nancy A., William D. Figg, Otis W. Brawley, et al.. (1998). Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal.. PubMed. 4(1). 37–44. 20 indexed citations
18.
Brawley, Otis W.. (1997). Prostate carcinoma incidence and patient mortality. Cancer. 80(9). 1857–1863. 99 indexed citations
19.
Figg, William D., Nancy A. Dawson, Otis W. Brawley, et al.. (1996). Flutamide Withdrawal and Concomitant Initiation of Aminoglutethimide in Patients with Hormone Refractory Prostate Cancer. Acta Oncologica. 35(6). 763–765. 8 indexed citations
20.
Feuer, Eric J., Otis W. Brawley, Susan Nayfield, et al.. (1994). After a treatment breakthrough: a comparison of trial and population-based data for advanced testicular cancer.. Journal of Clinical Oncology. 12(2). 368–377. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Limin X. Clegg Breakdown of academic impact, for papers by Vilma Cokkinides Breakdown of academic impact, for papers by Betsy Kohler Breakdown of academic impact, for papers by Michel P. Coleman Breakdown of academic impact, for papers by S. Jane Henley Breakdown of academic impact, for papers by Lawrence N. Shulman Breakdown of academic impact, for papers by Lori M. Minasian Breakdown of academic impact, for papers by Otis W. Brawley Breakdown of academic impact, for papers by Elizabeth Garrett‐Mayer Breakdown of academic impact, for papers by Kimberly Andrews
Rankless by CCL
2026